IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions

• Autori principali: Misuzu Okabayshi (Autore), Tatsuki R. Kataoka (Autore), Marina Oji (Autore), Satoko Mibayashi (Autore), Kentaro Odani (Autore), Atsushi Otsuka (Autore), Hironori Haga (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2020-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Insulin-like growth factor-2 messenger RNA-binding protein 3 (IGF2BP3 or IMP3) is an oncofetal protein that is expressed in various cancer types, and its expression is often associated with poor prognosis. IGF2BP3 expression has not been fully settled in vascular lesions. Methods...